This paper is in the following e-collection/theme issue:

#PREreview Live Review Report (11)

Published on in Vol 6 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71293, first published .
Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”

Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”

Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”

Authors of this article:

Vanessa Fairhurst1 ;   Randa Salah Gomaa Mahmoud2 Author Orcid Image ;   Toba Olatoye3 Author Orcid Image ;   Sylvester Sakilay Author Orcid Image
Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .